# A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

> **NCT01403636** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 167 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** SAR245409

## Key facts

- **NCT ID:** NCT01403636
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 167 (ACTUAL)
- **Last updated:** 2016-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01403636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01403636, "A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01403636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*